FFR and Inducible Myocardial Ischemia During Adenosine Stress Testing
Relationship Between Fractional Flow Reserve and Inducible Myocardial Ischemia During Adenosine Stress Testing
1 other identifier
interventional
150
1 country
1
Brief Summary
This is a prospective, single center study involving 150 patients with stable coronary artery disease undergoing coronary angiography for chest pain evaluation. The relationship between FFR values and inducible myocardial ischemia at the time of definite ischemia during adenosine stress testing will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 8, 2020
CompletedFirst Submitted
Initial submission to the registry
May 19, 2020
CompletedFirst Posted
Study publicly available on registry
May 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedJuly 21, 2021
July 1, 2021
1.6 years
May 19, 2020
July 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Definite myocardial ischemia
Echocardiographic wall motion score index score by 17-segment model or ST segment elevation/depression by 12-lead ECG during adenosine stress testing
during adenosine stress testing
Study Arms (1)
FFR Measurement
EXPERIMENTALMyocardia ischemia evaluation during adenosine stress testing
Interventions
ECG, FFR, and two-dimensional echocardiographic monitoring will be continued before, during and after adenosine infusion.
Eligibility Criteria
You may qualify if:
- Men or women at least 18 years of age
- Patients undergoing coronary angiography
- Moderate to severe stenosis (diameter stenosis equal or more than 50 percent by visual examination) in one major epicardial coronary artery
- Normal left ventricular function without regional wall motion abnormality
You may not qualify if:
- Contraindications to adenosine stress test\*
- ECG abnormalities (bundle branch block, LVH with strain, pacing rhythm, WPW)
- History of previous myocardial infarction
- Significant multi-vessel coronary artery disease (diameter stenosis equal or more than 50%)
- Hypertrophic cardiomyopathy
- Significant valvular heart disease
- Bronchial asthma or chronic obstructive lung disease
- Hepatic disease or biliary tract obstruction, or significant hepatic enzyme elevation (ALT or AST \> 3 times upper limit of normal).
- Current treatment for the active cancer
- Expected life expectancy \< 1 year
- Unwillingness or inability to comply with the procedures described in this protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asan Medical Center
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cheol Whan Lee, MD, PhD
Asan Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 19, 2020
First Posted
May 26, 2020
Study Start
May 8, 2020
Primary Completion
December 31, 2021
Study Completion
March 31, 2022
Last Updated
July 21, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share